Please Wait.....
Report
North America Organoids Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
Market Report I 2023-08-21 I 131 Pages I The Insight Partners
The North America organoids market is expected to grow from US$ 1,357.19 million in 2023 to US$ 3,585.62 million by 2028. It is estimated to record a CAGR of 21.4% from 2023 to 2028.
Growing Adoption of Personalized Drugs Fuels North America Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to the latest report by the PMC (published in 2021), in the US, the number of personalized medicines in the market has risen from 132 in 2016 to 286 in 2020. The data was shared by tracking the numbers of personalized medicine since 2008 by the PMC.
The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.
Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.
Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors might result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.
North America Organoids Market Overview
The North America organoids market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America organoids market. The rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development, growing commercialization of organoid models, and surging breakthroughs in stem cell research are the key factors propelling the market for organoids. Also, the growing funding and grants for organoid development are contributing to the growth of the market.
North America Organoids Market Revenue and Forecast to 2028 (US$ Million)
North America Organoids Market Segmentation
The North America organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the North America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the North America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the North America organoids market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
Corning Inc; Definigen; InSphero; Merck kGaA; Organoid Therapeutics; PeproTech, Inc.; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in North America.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Organoids Market - by Type
1.3.2 North America Organoids Market - by Application
1.3.3 North America Organoids Market - by Source
1.3.4 North America Organoids Market - by Country
2. North America Organoids Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Organoids Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion
5. North America Organoids Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. Organoids Market - North America Analysis
6.1 North America Organoids Market Revenue Forecast and Analysis
7. North America Organoids Market - Revenue and Forecast to 2028 - By Type
7.1 Overview
7.2 North America Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Organoids Market - Revenue and Forecast to 2028 - By Application
8.1 Overview
8.2 North America Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Organoids Market - Revenue and Forecast to 2028 - By Source
9.1 Overview
9.2 North America Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Organoids Market - Revenue and Forecast to 2028 - Country Analysis
10.1 North America Organoids Market
10.1.1 Overview
10.1.2 North America Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: North America Organoids Market, by Type, 2020-2028 (US$ Million)
10.1.2.1.4 US: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 US: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Canada: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: North America Organoids Market, by Type, 2020-2028 (US$ Million)
10.1.2.2.4 Canada: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Canada: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 Mexico: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: North America Organoids Market, by Type, 2020-2028 (US$ Million)
10.1.2.3.4 Mexico: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 Mexico: North America Organoids Market, by Source 2020-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Definigen
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Organoid Therapeutics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PeproTech, Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Corning Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 InSphero
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US North America Organoids Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. US North America Organoids Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 3. US North America Organoids Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada North America Organoids Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada North America Organoids Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada North America Organoids Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico North America Organoids Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico North America Organoids Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico North America Organoids Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Organoids Market Segmentation
Figure 2. North America Organoids Market by Country
Figure 3. North America Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in North America Organoids Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts' Opinion
Figure 8. North America Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. North America Organoids Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Organoids Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. North America Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. US: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Canada: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Mexico: North America Organoids Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security